S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

EyePod
25/04/2024 6 min Temporada 2 Episodio 38
S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

Listen "S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis"

Descargar episodio Ver en sitio original

Episode Synopsis

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis

More episodes of the podcast EyePod

Customized Clarity: Navigating IOL Options for Optimal Patient Care 23/12/2025
The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice 22/12/2025
Eichenbaum Acorns: Inside the mindset of an early adopter with Jordan Graff, MD 24/11/2025
Tsu Shan Chambers on "My Eyes" film: Bringing inherited eye disease to the screen 06/11/2025
Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists 06/11/2025
Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME 02/10/2025
NK Insights: An Interactive Corneal Sensitivity Testing Workshop 29/08/2025
3 Things You Should Know About Interventional Glaucoma Comanagement 04/06/2025
3 Things You Should Know About Early Treatment Intervention for TED 30/05/2025
Patient-Centered Treatment Strategies in the Management of nAMD and DME 30/05/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA